| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017154 |
| Receipt No. | R000019899 |
| Official scientific title of the study | Effects on glucose loading on cerebral glucose metabolism |
| Date of disclosure of the study information | 2015/05/01 |
| Last modified on | 2016/05/06 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Effects on glucose loading on cerebral glucose metabolism | |
| Title of the study (Brief title) | Effects on glucose loading on cerebral glucose metabolism | |
| Region |
|
|
| Condition | ||
| Condition | healthy volunteers | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Investigating the relationships between glucose loading and cerebra glucose metabolism |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Changes in regional glucose metabolism after glucose loading |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Administration of glucose 75g | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. The subjects who have intention to participate in this study, and signed informed consent.
2. Male and female subjects of >=60 and <90 years, old. 3. The subjects who are healthy |
|||
| Key exclusion criteria | 1. The subjects with a history of brain diseases, excluding than cerebellar diseases.
2. The subjects who are prescribed a medication for the central nervous system. 3. The subject who have chronic dysfunction in the organs. 4. Pregnant or woman who has a chance of pregnant. 5. The subjects who were judged by the clinical investigator to be inappropriate as a participant in this study. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Kenji Ishibashi |
| Organization | Tokyo Metropolitan Institute of Gerontology |
| Division name | Research Team for Neuroimaging |
| Address | 35-2, Sakae-cho, Itabashi-ku, Tokyo |
| TEL | 03-3964-3241 |
| ishibashi@pet.tmig.or.jp | |
| Public contact | |
| Name of contact person | Kenji Ishibashi |
| Organization | Tokyo Metropolitan Institute of Gerontology |
| Division name | Research Team for Neuroimaging |
| Address | 35-2, Sakae-cho, Itabashi-ku, Tokyo |
| TEL | 03-3964-3241 |
| Homepage URL | |
| ishibashi@pet.tmig.or.jp | |
| Sponsor | |
| Institute | Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019899 |